Effect of dosage form on stereoisomeric inversion of ibuprofen in volunteers

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 6, 1999, Pages 616-622

  Aiba, Tetsuya ^a   Tse, Mary M ^b   Lin, Emil T ^b   Koizumi, Tamotsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dosage form; Healthy volunteer; Human liver microsome; Ibuprofen; Stereospecific inversion

Indexed keywords

IBUPROFEN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG ELIMINATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; STEREOISOMERISM; STOMACH EMPTYING;

EID: 0032973191     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.616     Document Type: Article

References (24)

1. Lee E. J. D., Williams K., Day R., Graham G., Champion D., Br. J. Clin. Pharmacol., 19, 669-674 (1985).
2. Jamali F., Mehvar R., Russell A. S., Sattari S., Yakimets W. W., Koo J., J. Pharm. Sci., 81, 221-225 (1992).
3. Knihinicki R. D., Williams K. M., Day R. O., Biochem. Pharmacol., 38, 4389-4395 (1989).
4. Chen C.-S., Shieh W.-R., Lu P.-H., Harriman S., Chen C.-Y., Biochim. Biophys. Acta, 1078, 411-417 (1991).
5. Shieh W.-R., Chen C.-S., J. Biol. Chem., 268, 3487-3493 (1993).
6. Chen C.-S., Chen T., Shieh W.-R., Biochim. Biophys. Acta, 1033, 1-6 (1990).
7. Baillie T. A., Adams W. J., Kaiser D. G., Olanoff L. S., Halstead G. W., Harpootlian H., Van Giessen G. J., J. Pharmacol. Exp. Ther., 249, 517-523 (1989).
8. Hall S. D., Rudy A. C., Knight P. M., Brater D. C., Clin. Pharmacol. Ther., 53, 393-400 (1993).
9. Cheng H., Rogers J. D., Demetriades J. L., Holland S. D., Seibold J. R., Depuy E., Pharmaceut. Res., 11, 824-830 (1994).
10. Jamali F., Singh N. N., Pasutto F., Russel A. S., Coutts R. T., Pharmaceut. Res., 5, 40-43 (1988).
11. Berry B. W., Jamali F., J. Pharmacol. Exp. Ther., 258, 695-701 (1991).
12. Wright M. R., Sattari S., Brocks D. R., Jamali F., J. Chromatogr., 583, 259-265 (1992).
13. Wright M. R., Jamali F., J. Chromatogr., 616, 59-65 (1993).
14. Lemko C. H., Caille G., Foster R. T., J. Chromatogr., 619, 330-335 (1993).
15. Lockwood G. F., Albert K. S., Gillespie W. R., Bole G. G., Harkcom T. M., Szpunar G. J., Wagner J. G., Clin. Pharmacol. Ther., 34, 97-103 (1983).
16. Bolondi L., Bortolotti M., Santi V., Calletti T., Gaiani S., Labo G., Gastroenterology, 89, 752-759 (1985).
17. Madsen J. L., Jensen M., J. Nucl. Med., 30, 402-406 (1989).
18. Devereux J. E., Newton J. M., Short M. B., J. Pharm. Pharmacol., 42, 500-501 (1990).
19. Dressman J. B., Berardi R. R., Elta G. H., Gray T. M., Montgomery P. A., Lau H. S., Pelekoudas K. L., Szpunar G. J., Wagner J. G., Pharmaceut. Res., 9, 901-907 (1992).
20. Pratt W. B., "Principles of Drug Action 3/e," ed. by Pratt W. B., Taylor P., Churchill Livingstone, New York, 1990, pp. 201-296.
21. Yasui H., Yamaoka K., Dote N., Nakagawa T., J. Pharm. Sci., 84, 1327-1331 (1995).
22. Seddon T., Michelle I., Chenery R. J., Biochem. Pharmacol., 38, 1657-1665 (1989).
23. Bayliss M. K., Bell J. A., Jenner W. N., Wilson K., Biochem. Soc. Trans., 18, 1198-1199 (1990).
24. Jacolot F., Simon I., Dreano Y., Beaune P., Riche C., Berthou F., Biochem. Pharmacol., 41, 1911-1919 (1991).